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Original Article
MRSA Breast Abscesses in Postpartum Women
E.W.L. Chuwa, C.M.Y. Wong, Y.Y. Tan and G.S. Hong, Breast Unit, KK Women’s and Children’s Hospital, Singapore.
BACKGROUND: Infections caused by community-acquired methicillin-resistant Staphylococcus aureus
(CA-MRSA) are being increasingly observed in patients who lack traditional risk factors. While mastitis
and breast abscesses are commonly encountered in post-natal women, CA-MRSA breast infections have
rarely been reported.
MATERIALS AND METHODS: We reviewed 15 postpartum women with methicillin-resistant
Staphylococcus aureus (MRSA) breast abscesses observed in our unit from June 2005 to April 2007. Ultra-
sonographic examination was performed in all cases. MRSA infection was diagnosed on microbiological
analysis cultured from the abscesses of these patients.
RESULTS: The median age of the patients was 31.5 years. The majority of the patients were primiparae
(80%). Only one patient was immunocompromised. None of the patients had history of previous breast
infection and none developed recurrence. Eleven patients (73.3%) underwent aspiration of pus and four
patients (26.7%) underwent incision and drainage. All the cultures were sensitive to co-trimoxazole and
vancomycin. Eight (53.3%) of the cultures were also sensitive to erythromycin.
CONCLUSION: CA-MRSA is an emerging problem in our obstetric population. CA-MRSA breast infec-
tions are clinically responsive to common oral antibiotics such as co-trimoxazole and erythromycin. 
A high index of suspicion is essential to avoid delay in the clinical response to empirical beta-lactams as
these patients may benefit from an early change of antibiotics. [Asian J Surg 2009;32(1):55–8]
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Introduction
Mastitis is a common problem in postpartum women,
especially those who are breastfeeding. It occurs within 
6 weeks of delivery with reported rates ranging from 1% to
33%.1 About 4.6% to 11% of these women with mastitis
progressed to abscess formation if treatment is delayed.2,3
The bacteria involved are usually Staphylococcus aureus,
coagulase negative staphylococci and anaerobes.4 However,
cases of breast infections secondary to community-acquired
methicillin-resistant Staphylococcus aureus (CA-MRSA) have
been increasingly reported among postpartum women
who lack traditional risk factors.1,5,6 MRSA is known to be
associated with prolonged hospital care and indwelling
medical devices and hence an unlikely pathogen for such
community-acquired infections. These breast infections
respond poorly to the usual beta-lactams and frequently
present as abscesses due to delay in appropriate treat-
ment. This results in significant morbidity and interferes
with continued breastfeeding.
Mastitis and breast abscesses caused by MRSA have
rarely been described. Our study describes the presenta-
tion and outcome of MRSA breast infections in 15 post-
partum women treated at our unit and aims to review the
current literature surrounding this infection.
Methods
The medical records of post-natal nursing women who were
diagnosed with MRSA breast abscesses at KK Women’s
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and Children’s Hospital during the period June 2005 to
April 2007 were reviewed. The data was retrieved from the
departmental computerised database after seeking approval
from the KK Hospital Institutional Review Board.
Ultrasonographic examination was performed in all
cases. Breast abscess was diagnosed as a fluctuant mass in
addition to inflammatory findings. This was confirmed
by bedside ultrasound examination as an anechoic collec-
tion containing low level internal echoes surrounded 
by an echogenic rim. All patients were given 625 mg
amoxicillin/clavilunate orally and twice daily for 1 week
(or 500 mg ciprofloxacin twice daily in one case with a
penicillin allergy) as empirical treatment after obtaining
pus cultures. Aspiration was performed at the bedside
with a 16-gauge needle. When successful at first attempt,
aspiration was performed every 2–3 days until the breast
was clear of any collection on ultrasound. If aspiration
was hampered by thick viscid pus and multiple locula-
tions within the abscess cavity; or the patient refused per-
cutaneous aspiration; surgical drainage was performed on
the same day. The sample of pus obtained was sent for
bacteriological examination. All patients were treated on
an outpatient basis and followed up until clinical and
sonographic resolution of abscesses.
The following parameters were recorded: patient age,
parity, comorbid conditions, prior history of breast infec-
tions, duration of lactation, duration of symptoms, side
of affected breast, abscess diameter, treatment details
including types of antibiotics prescribed, pus culture re-
sults, method of drainage, number of aspiration attempts,
time to clinical resolution and recurrence.
Results
A total of 15 cases of MRSA breast abscesses were studied
during the period of review (Table). The median age of the
patients was 31 (range, 24–38) years. The majority of
patients (80%) were primiparae and there was no predilec-
tion of laterality of breast involvement with the right
breast affected in 8 (53.3%) patients and the left breast in
7 (46.7%) patients. The median duration of follow-up was
9 months (range, 1–26 months).
One patient had systemic lupus erythematosus on
immunosuppressants and one other patient had mild
gestational diabetes. The rest of the patients had no sig-
nificant comorbidities. None of the patients had previous
breast abscesses or demonstrated recurrence during the
period of follow-up. Our patients developed the abscesses
at a median of 5 weeks (range, 3–16 weeks) postpartum.
The duration of symptoms prior to consultation with a
breast specialist ranged from 5 to 31 days (median, 14
days). The median size of the abscesses was 4.3 cm (range,
2.0–10.0 cm). Histology was documented for 5 (33.3%) of
the cases and none showed malignancy.
Table. Characteristics of patients studied
Patient
Date of Age 
Parity
Post-delivery Duration of Side of Abscess Method of Number of 
presentation (yr) (wk) symptoms (d) abscess size (cm) drainage aspirations
1 27/6/05 33 2 12 7 Right 5.0 I&D NA
2 18/9/05 31 1 8 7 Right 4.0 I&D NA
3 9/12/05 30 2 5 5 Left 6.0 Asp 3
4 12/4/06 24 1 3 14 Left 10.0 I&D NA
5 11/7/06 34 1 12 21 Left 5.0 I&D NA
6 12/7/06 29 1 4 14 Right 2.5 Asp 1
7 12/12/06 33 1 3 14 Right 5.0 Asp 3
8 7/12/06 30 1 12 11 Left 4.0 Asp 3
9 5/1/07 31 1 9 14 Right 4.3 Asp 3
10 7/2/07 31 1 5 14 Left 3.4 Asp 3
11 12/2/07 38 2 8 14 Left 4.0 Asp 2
12 12/3/07 38 1 8 14 Right 10.0 Asp 2
13 30/3/07 32 1 4 14 Left 2.5 Asp 1
14 3/4/07 34 1 4 7 Right 2.0 Asp 1
15 10/8/07 29 1 3 7 Right 8.0 Asp 3
I&D = incision and drainage; Asp = percutaneous aspiration; NA = not applicable.
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Twelve patients (80%) were treated with only amoxi-
cillin/clavilunate before culture results were available.
One patient had both amoxicillin/clavilunate and cloxa-
cillin for 1 week. One patient had amoxicillin/clavilunate
for 4 days and ciprofloxacin for 2 days, and one patient
was given only ciprofloxacin due to a penicillin allergy. 
A change of antibiotics to co-trimoxazole was instituted
in 9 patients (60%) according to bacteriological culture
and sensitivity once results were available. The overall
median duration of antibiotics was 14 days (range, 7–26
days). All the cultures of MRSA were sensitive to co-
trimoxazole and vancomycin. Eight (53.3%) of the cultures
were also sensitive to erythromycin.
The majority of our patients (73.3%) were treated with
aspiration. More than half of these patients (54.5%)
required aspiration on more than two consecutive visits.
The resulting success rate of percutaneous aspiration
without resorting to surgical drainage was 100%. The
median time to complete clinical resolution in this group
was 16 days (range, 5–28 days). In contrast, this period for
the patients who underwent surgical drainage was 21 days
(range, 5–28 days). There were no recurrences observed
during follow-up.
Discussion
Reports of postpartum MRSA infections among young,
immunocompetent women lacking traditional risk fac-
tors for MRSA have surfaced in the past few years.1,5,6
Isolates in these cases of CA-MRSA are susceptible to
multiple non-beta-lactam antibiotics and possess distinct
molecular features.7 In our institution, MRSA breast
abscesses appear to be an emerging problem. We consid-
ered CA-MRSA as the causative agent because the isolates
in our study were unusually susceptible to non-beta-lactam
antibiotics.
Multisusceptible MRSA is not new in Singapore.8
Analysis of hospital-acquired MRSA strains isolated from
two tertiary public hospitals in Singapore in 2004 observed
a progressive increase in the number of cases since 2002
and that multisusceptible strains were gradually replac-
ing the endemic multiresistant strain (ST239-MRSA-III).
Molecular typing confirmed a predominant clonal out-
break of a UK-EMRSA-15 strain.9 A recent update involv-
ing all the tertiary public hospitals in Singapore showed 
a rapidly increasing spread of the EMRSA-15 clone 
from MRSA isolates, replacing the endemic ST239 clone
island-wide by the first half of 2006.9 EMRSA-15 emerged
as a significant nosocomial pathogen in the United
Kingdom in 1991 and is at present one of the two predom-
inant health-care-associated MRSA (HA-MRSA) clones in
the country, having replaced most of the other HA-MRSA
clones in the first decade of its emergence.11 Typing of the
isolates in our study will be helpful to determine if they
are of the same strain as EMRSA-15.
In contrast to hospital-acquired MRSA, CA-MRSA
possess differing virulence genetic profiles and cause a
distinct spectrum of infections in the young and immuno-
competent who lack traditional risk factors for MRSA
infections. While the majority of CA-MRSA breast abscesses
are generally susceptible to most non-beta-lactam antibi-
otics, resistance to various older non-beta-lactam antibi-
otics may be relatively easily acquired. Widespread use of
clindamycin had resulted in a small but significant rise in
resistance within 2 years in northeast USA.12 Pus culture
sensitivity results confirmed the multisusceptibility nature
of the strain of MRSA in our study. Although all the iso-
lates were sensitive to vancomycin, none of our patients
presented with signs of systemic septicaemia hence routine
admission for intravenous vancomycin was not deemed
necessary. However, it remains important that patients
with MRSA infections should be evaluated based on their
culture sensitivity results and treated accordingly. Serial
follow-up to ensure resolution is also important to pre-
vent sub optimal treatment and recurrence. Interestingly,
in about 40% of cases in the current study, the infection
resolved with surgical management and empiric antibio-
tics to which the isolate was later found to be resistant.
This was not influenced by the method of drainage as 50%
of these patients underwent surgical drainage and the rest
underwent percutaneous aspiration. This supports an
observation from a recent study that up to 30% of MRSA
soft tissue infections recovered uneventfully after surgical
drainage, even when treated with antibiotics that were inef-
fective based on culture sensitivity results.13 This remains
a controversial point and well-designed clinical trials are
needed before antimicrobials may be routinely omitted as
part of treatment. However, it is noteworthy that our study
has shown that surgical drainage may not necessarily be
more advantageous over less invasive drainage procedures
even in the management of MRSA infections.
In our study, all the patients achieved clinical resolu-
tion within a median of 16 days (range, 5–28 days) on out-
patient treatment with oral antibiotics and aspiration or
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surgical drainage of the abscesses. This is comparable to
studies on non-MRSA lactational breast abscesses.2,14
In our cohort of 15 patients, the majority (73.3%) were
treated by aspiration of pus. While incision and drainage
have been recommended by several authors over percuta-
neous aspiration for abscesses larger than 5 cm2, we did
not adopt such a size criterion for our practice. We believe
that we managed to achieve high success rates in percuta-
neous aspiration of abscesses because of routine bedside
ultrasonography for all patients. This practice not only
helped with diagnosis and selection of patients for either
method of drainage; but also helped guide needle place-
ment for cases that underwent percutaneous aspiration.
All the patients in our study presented with delivery
dates that spanned more than 9 months without overlap,
suggesting that MRSA was independently acquired rather
than outbreak-related. Previous authors have observed a
predilection for such infections in multiparous women,
involvement of multiple sites and recurrent infections.5
We did not observe such a trend in our patients as the
majority of our patients are primiparous (78.6%) and none
had recurrence or involvement of more than one site. This
could be explained by the high incidence of comorbid
conditions (33%) in their cohort compared to our study
(6.7%). Also, previous authors have demonstrated the ben-
efits of breast emptying and reinforcement of nursing
techniques in the process of treating lactational breast
abscesses.15,16 Milk stasis due to insufficient nursing tech-
niques has been proposed as an excellent culture media
for microorganisms. It is therefore no surprise that the
majority of our patients are primiparae.
It is important to recognise that the remarkable suc-
cess in dissemination of EMRSA-15 in our community
within 4 years since its entry highlights the lack of control
over the spread of this clone. While there are clearly short-
term advantages in having multisusceptible MRSA
replace the multiresistant strains, including more antimi-
crobial options for treating such infections, standard con-
tact precautions and proper hand hygiene cannot be
overemphasised. Proper decontamination is mandatory
for breast pumps and accessories.
The emergence of CA-MRSA infection is set to alter
healthcare practices in our communities. The prevalence
in our population is still not known and additional stud-
ies are needed. However, the medical community needs to
be aware of the current trend. Empirical treatment of
community-acquired mastitis with beta-lactam agents
without culturing specimens obtained from the infected
site may no longer be appropriate. Active surveillance for
CA-MRSA infections and colonisation and molecular
studies of virulence factors are critical to a complete under-
standing of the epidemiology of this emerging pathogen.
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